Kaitlyn D’Onofrio

DocwireNews

Flares in rheumatoid arthritis (RA) are associated with worse disease activity, quality of life, and radiographic progression, and evidence shows that even RA patients with low disease activity (LDA) still experience these episodes.&nbsp;Eligible participants were those taking&nbsp;disease-modifying antirheumatic drugs and&nbsp;who&nbsp;had a stable 28-joint count Disease Activity Score (DAS28) &lt; 3.2. Researchers collected&nbsp;clinical&nbsp;(DAS28)&nbsp;functional&nbsp;(Health Assessment Questionnaire&ndash;Disability Index&nbsp;[HAQ-DI], EQ-5D, Functional Assessment of Chronic Illness Therapy Fatigue scale&nbsp;[FACIT-F],&nbsp;Medical Outcomes Study Short Form-36&nbsp;(SF-36]), serum biomarkers&nbsp;(multibiomarker&nbsp;disease activity&nbsp;[MBDA]&nbsp;score, calprotectin, CXCL10), and imaging data at baseline and every three months for one year. An increase in DAS28 compared with baseline of &gt; 1.2, or &gt; 0.6 if concurrent DAS28 &ge; 3.2&nbsp;was considered a flare.&nbsp;The study included 152 patients.&nbsp;<a href="https://twitter.com/Orthopedics_Bio/status/1036687150916329479">https://twitter.com/Orthopedics_Bio/status/1036687150916329479</a>During the study period, 30% of patients (n = 46) had a flare.&nbsp;Of patients who were in remission at the start of the study, 25% (n = 24) had a flare.&nbsp;In unadjusted and multivariate analyses, HAQ-DI was associated with higher risk of flares (unadjusted hazard ratio [HR], 1.82 [95% CI 1.20-2.72]; adjusted HR, 1.76 [95% CI 1.05-2.93]).&nbsp;EQ-5D was correlated with lower risk of flare (HR,&nbsp;0.20 [95% CI 0.07-0.57]). Only one-third of flares were associated with increased biomarkers. Patients with flares had significantly worse outcomes after one year&nbsp;(HAQ-DI, EQ-5D, FACIT-F, SF-36, and radiographic progression).&nbsp;<blockquote class="twitter-tweet" data-width="500" data-dnt="true">
New: What signs predict a flare in rheumatoid arthritis? <a href="https://t.co/dXfkTEyk2i">https://t.co/dXfkTEyk2i</a> via <a href="https://twitter.com/medivizor?ref_src=twsrc%5Etfw">@medivizor</a> <a href="https://twitter.com/hashtag/Rheum?src=hash&amp;ref_src=twsrc%5Etfw">#Rheum</a>
&mdash; Medivizor (@medivizor) <a href="https://twitter.com/medivizor/status/1047353935776894976?ref_src=twsrc%5Etfw">October 3, 2018</a>
</blockquote><script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>&ldquo;It is possible that a flare event is not solely the result of direct synovial inflammation but may be driven by other pathways, for example&nbsp;chronification&nbsp;of pain due to central sensitization and abnormal regulatory mechanisms. This heterogeneity may partly explain why identifying predictors of flare is challenging,&rdquo;&nbsp;the researchers wrote.&nbsp;The study authors concluded that&nbsp;&ldquo;the occurrence of a flare is hard to predict, but undeniably associated with worse clinical outcomes at 12 months.&rdquo;&nbsp;<a href="https://proddocwire.wpengine.com/rheumatology/men-with-rheumatoid-arthritis-struggle-to-cope/">Men with Rheumatoid Arthritis Struggle to Cope</a>&nbsp;<a href="https://proddocwire.wpengine.com/docwire-pick/prevent-delay-rheumatoid-arthritis/">Therapeutic Interventions to Prevent and Delay Rheumatoid Arthritis Onset</a>&nbsp;<a href="https://proddocwire.wpengine.com/docwire-pick/on-the-defense-diagnosing-rheumatoid-arthritis-before-it-starts/">On the Defense: Diagnosing Rheumatoid Arthritis Before It Starts</a>&nbsp;Sources:&nbsp;<a href="http://www.jrheum.org/content/early/2018/08/27/jrheum.171375">The&nbsp;Journal of Rheumatology</a>,&nbsp;<a href="https://www.mdedge.com/rheumatologynews/article/175019/rheumatoid-arthritis/predictors-worse-outcomes-low-disease-activity">Rheumatology News</a>

Bradley Marder, MD

Joel M. Topf, MD, FACP

Gout Studies: Transplant Waitlisting and Bone Erosion

NKF Spring Clinical Meetings 2025

Jayme Locke, MD, MPH

The Promise of Xenotransplantation

Leah Lawrence

Real-World Data Backs Invasive DFS as Surrogate Endpoint for OS in EBC

HR Breast Cancer

Latest News

Rheumatoid Arthritis Patients with Low Disease Activity Still Have Flareups 

Rheumatoid Arthritis

Flares in rheumatoid arthritis (RA) are associated with worse disease activity, quality of life, and radiographic progression, and evidence shows that even RA patients with ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe